Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Volpe

Showing results (191-200 of 820) with videos related to

Pageof 82
Sort By:
European Heart Journal|November 12, 2022
Benefits of SGLT2i in heart failure across a broad range of ejection fractions: new opportunities and future challengesMassimo Volpe, Carlo Patrono
European Heart Journal|April 21, 2025
Weekly Journal Scan: a large observational study unravels the wide-ranging effects of glucagon-like peptide-1 receptor agonistsDaniela Pedicino, Massimo Volpe
European Heart Journal|April 15, 2025
Weekly Journal Scan: a deep insight into aldosterone antagonism across the heart failure spectrumDaniela Pedicino, Massimo Volpe
European Heart Journal|July 10, 2025
Weekly Journal Scan: BedMed cannot overcome the uncertainties on the effects of night-time antihypertensive therapy on cardiovascular outcomesGiovanna Gallo, Massimo Volpe
European Heart Journal|May 5, 2021
Vulnerable non-culprit coronary plaques: are they worth treating?Massimo Volpe, Carlo Patrono
European Heart Journal|August 1, 2021
The key role of blood pressure lowering in cardiovascular prevention irrespective of baseline blood pressure and risk profileMassimo Volpe, Carlo Patrono
European Heart Journal|August 5, 2021
Exploring RNA biomarkers in patients with acute myocarditisFrancesco Paneni, Massimo Volpe
European Heart Journal|February 14, 2023
The 'cold case' of chlortalidone vs. hydrochlorothiazide in hypertension closed by the diuretic comparison project?Massimo Volpe, Giovanna Liuzzo
European Heart Journal|August 8, 2022
Atrial fibrosis detected by cardiac magnetic resonance in persistent atrial fibrillation: a useful risk stratifier but not ideal electrophysiological endpoint for catheter ablationMaria Lucia Narducci, Massimo Volpe
European Heart Journal|January 31, 2022
Implantable recorders and systematic atrial fibrillation detection do not outperform standard of care in stroke prevention in the LOOP studyMaria Lucia Narducci, Massimo Volpe
Pageof 82

Showing results (191-200 of 820) with videos related to

Sort By:
Pageof 82
European Heart Journal|November 12, 2022
Benefits of SGLT2i in heart failure across a broad range of ejection fractions: new opportunities and future challengesMassimo Volpe, Carlo Patrono
European Heart Journal|April 21, 2025
Weekly Journal Scan: a large observational study unravels the wide-ranging effects of glucagon-like peptide-1 receptor agonistsDaniela Pedicino, Massimo Volpe
European Heart Journal|April 15, 2025
Weekly Journal Scan: a deep insight into aldosterone antagonism across the heart failure spectrumDaniela Pedicino, Massimo Volpe
European Heart Journal|July 10, 2025
Weekly Journal Scan: BedMed cannot overcome the uncertainties on the effects of night-time antihypertensive therapy on cardiovascular outcomesGiovanna Gallo, Massimo Volpe
European Heart Journal|May 5, 2021
Vulnerable non-culprit coronary plaques: are they worth treating?Massimo Volpe, Carlo Patrono
European Heart Journal|August 1, 2021
The key role of blood pressure lowering in cardiovascular prevention irrespective of baseline blood pressure and risk profileMassimo Volpe, Carlo Patrono
European Heart Journal|August 5, 2021
Exploring RNA biomarkers in patients with acute myocarditisFrancesco Paneni, Massimo Volpe
European Heart Journal|February 14, 2023
The 'cold case' of chlortalidone vs. hydrochlorothiazide in hypertension closed by the diuretic comparison project?Massimo Volpe, Giovanna Liuzzo
European Heart Journal|August 8, 2022
Atrial fibrosis detected by cardiac magnetic resonance in persistent atrial fibrillation: a useful risk stratifier but not ideal electrophysiological endpoint for catheter ablationMaria Lucia Narducci, Massimo Volpe
European Heart Journal|January 31, 2022
Implantable recorders and systematic atrial fibrillation detection do not outperform standard of care in stroke prevention in the LOOP studyMaria Lucia Narducci, Massimo Volpe
Pageof 82